Modulation of tumoricidal function in alveolar macrophages from lung cancer patients by interleukin-6

Cancer Immunology Immunotherapy

Volumn 45, Issue 1, 1997, Pages 37-44

  Ahn, Mi Chung ^a   Siziopikou, Kalliopi P ^a   Plate, Janet M D ^a   Casey, Larry ^a   Silver, Mike ^a   Harris, Jules E ^a   Braun, Donald P ^a  

^a RUSH UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

Alveolar macrophages; Interleukin 6; Lung cancer; PBL; Tumoricidal activity

Indexed keywords

GAMMA INTERFERON; INTERLEUKIN 1ALPHA; INTERLEUKIN 1BETA; INTERLEUKIN 6; LIPOPOLYSACCHARIDE; MESSENGER RNA; TUMOR NECROSIS FACTOR ALPHA;

ANTINEOPLASTIC ACTIVITY; ARTICLE; CELL MEDIATED CYTOTOXICITY; CLINICAL ARTICLE; CONTROLLED STUDY; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOMODULATION; LUNG ALVEOLUS MACROPHAGE; LUNG CANCER; MACROPHAGE ACTIVATION; MESSENGER RNA SYNTHESIS; NATURAL KILLER CELL; PERIPHERAL LYMPHOCYTE; PRIORITY JOURNAL;

ANTIBODIES; COCULTURE TECHNIQUES; CYTOKINES; CYTOTOXICITY, IMMUNOLOGIC; HUMANS; INTERFERON TYPE II; INTERLEUKIN-6; LIPOPOLYSACCHARIDES; LUNG NEOPLASMS; LYMPHOCYTES; MACROPHAGE ACTIVATION; MACROPHAGES, ALVEOLAR; RNA, MESSENGER;

EID: 0030771127     PISSN: 03407004     EISSN: None     Source Type: Journal    
DOI: 10.1007/s002620050398     Document Type: Article

References (36)

1. Adams DO, Hamilton TA (1984) The cell biology of macrophage activation. Annu Rev Immunol 2:283-318
2. Akira S, Taga T, Kishimoto T (1993) Interleukin-6 in biology and medicine. Adv Immunol 54:1-78
3. Bataille R, Jorudan M, Zhang XG, Klein B (1989) IL-6 is a potent grown factor for plasma cells and is elevated in overt myeloma and plasma cell leukemia. J Clin Invest 84:2008-2011
4. Braun DP, Siziopikou KP, Casey L, Harris JE (1990) Augmentation of impaired tumoricidal function in alveolar macrophages from lung cancer patients by cocultivation with allogeneic lymphocytes. Proc Am Assoc Cancer Res 31:244
5. De Waal Malefyt R, Abrams J, Bennett B, Figdor CG, Vries JE de (1991) Interleukin 10 (IL-10) inhibits cytokine synthesis by human monocytes: an autoregulatory role of IL-10 produced by monocytes. J Exp Med 174:1209-1220
6. Frishman J, Long B, Knospe W, Gregory S, Plate J (1993) Genes for interleukin 7 are transcribed in leukemic cell subsets of individuals with chronic lymphocytic leukemia. J Exp Med 177:955-964
7. Gangmi JD, Olsen GN, Fechtez C, Hightower JA, Bauguess CT, Krech L (1985) Phagocytic activity of alveolar macrophages in patients with bronchogenic carcinoma. Cancer Immunol Immunother 20:158-166
8. Gibbons R, Martinez O, Matli M, Heinel F, Bernstein M, Warren R (1990) Recombinant IL-4 inhibits IL-6 synthesis by adherent peripheral blood cells in vitro. Lymphokine Res 9:283-293
9. Girasole G, Jilka RL, Passeri G, Boswell S, Boder G, Williams DC, Manologas SC (1992) Estradiol inhibits interleukin-6 production by bone marrow-derived stromal cells and osteoblasts in vitro: a potential mechanism for the antiosteoporotic effect of estrogens. J Clin Invest 89:883-891
10. Guerne PA, Zuraw BI, Vaughan JH, Carson DA, Lotz M (1989) Synovium as a source of interleukin 6 in vitro. Contribution to local and systemic manifestation of arthritis. J Clin Invest 83:585-592
11. Helfgott DC, May LT, Stoeger Z, Tamm I, Segal PB (1987) Bacterial lipopolysaccharide enhances expression and secretion of β2 interferon by human fibroblast. J Exp Med 166:1300-1309
12. Helle M, Brankenhoff J, Aarden L (1992) Interleukin-6: its role in the cytokine network. In: Furth R van (ed) Mononuclear phagocytes. Kluwer Academic, London New Yor, pp 333-339
13. Hirano T, Taga T, Yasukawa K, Nakajima K, Nakano N, Takatshuki F, Shimizu M, Murashima A, Tsunasawa S, Sakiyama F, Kishimoto T (1987) Human B cell differentiation factor defined by anti-peptide antibody and its possible role in auto-antibody production. Proc Natl Acad Sci USA 84:228-231
14. Kan-Mitchell J, Hengst JCD, Kempf RA, Rothbart RK, Simons SM, Brooker AS, Kortes VL, Mitchell MS (1985) Cytotoxic activity of human pulmonary alveolar macrophages.Cancer Res 45:453-458
15. Klein B, Lu ZU, Bataille R (1992) Clinical application of IL-6 inhibitors. Res Immunol 143:774-776
16. Kohase M, Henriksen-DeStefano D, May LT, Vilcek J, Sehgal PB (1986) Induction of β2-interferon by tumor necrosis factor: a homeostatic mechanism in the control of cell proliferation. Cell 46:659-666
17. Kuda T, Yasumoto K, Yano T, Nukahashi H, Sugimashi K, Nomoto K (1987) Role of antitumor activity of alveolar macrophages in lung cancer patients. Cancer Res 47:2199-2202
18. Miles SA, Rezai AR, Salazar-Gonzales JF, Meyden MV, Stevens RH, Logan DM, Mitsuyasu RT, Taga T, Hirano T, Kishimoto T, Martinez-Maza O (1990) AIDS Kaposi's sarcoma-derived cells produce and respond to interleukin-6. Proc Natl Acad Sci USA 87:4068-4072
19. Nakafaku M, Satoh T, Kaziro Y (1992) Differentiation factors, including nerve growth factor, fibroblast growth factor, and interleukin-6, induce accumulation of an active ras-GTP complex in rat pheochromocytoma PC 12 cells. J Biol Chem 267:19 448-19 454
20. Nakajima T, Wall R (1991) Interleukin-6 signals activating junB and tis11 gene transcription in a B cell hybridoma. Mol Cell Biol 11:1409-1418
21. Nakajima T, Kinoshita S, Sasagawa T, Sasaki K, Naruto M, Kishimoto T, Akira S (1993) Phosphorylation at threonine 235 by a ras dependent MAP kinase cascade is essential for transcriptional activation of NF-IL6. Proc Natl Acad Sci USA 90:2207-2211
22. Nathan CF, Murray HW, Wiebe ME, Rubin BY (1983) Identification of interferon-gamma, as the lymphokine that activates human macrophage oxidative metabolism and antimicrobial activity. J Exp Med 158:670-689
23. Natsuka S, Akira S, Sugita T, Hashimoto S, Nishio Y, Isshiki H, Kishimoto T (1992) Macrophage differentiation specific expression of NF-IL-6, a transcription factor for IL-6. Blood 79:460-466
24. Sanceau J, Beranger F, Gaudelt C, Wietzerbin J (1989) IFN-γ is an essential cosignai for triggering IFN-β2 gene expression in human monocytic cell lines. Ann N Y Acad Sci 557:130-143
25. Sehgal PB, Walther Z, Tamm I (1987) Rapid enhancement of β2-IFN/BSF-2 gene expression in human fibroblasts by diacylglycerols and the calcium ionophore A23187. Proc Natl Acad Sci USA 84:3633-3667
26. Sipe JD, Bartle LM, Loose LD (1992) Modification of proinflammatory production by the antirheumatic Tenidap and Naproxen. A possible correlate with clinical acute phase response. J Immunol 148:480-484
27. Siziopikou KP, Harris JE, Casey L, Nawas Y, Braun DP (1991) Impaired tumoricidal function of alveolar macrophages from patients with non-small cell lung cancer. Cancer 68:1035-1044
28. Sone SO (1986) Role of alveolar macrophages in pulmonary neoplasias. Biochim Biophys Acta 823:2227-2245
29. Swinburne S, Moore M, Cole P (1982) Human bronchoalveolar macrophage cytotoxicity for cultured human lung tumor cells. Br J Cancer 46:625-634
30. Taga T, Hibi M, Hirata Y, Yamasaki K, Yasukawa K, Matsuda T, Hirano T, Kishimoto T (1989) Interleukin-6 triggers the association of its receptor with a possible signal transducer, gp 130. Cell 58:573-581
31. Thomassen MJ, Wiedemann HP, Barna BP, Farmer M, Ahmad M (1988) Induction of in vitro tumoricidal activity in alveolar macrophages and monocytes from patients with lung cancer. Cancer Res 48:3949-3953
32. Vink A, Coulie PG, Warnier G, Renauld JC, Stevens M, Donkers P Van Snick J (1990) Mouse plasmacytoma growth in vivo: enhancement by interleukin-6 and inhibition by antibodies directed against interleukin-6 or its receptor. J Exp Med 172:997-1000
33. Waage A, Slupphaug G, Shalaby R (1990) Glucocorticoids inhibit the production of IL-6 from monocytes, endothelial cells and fibroblasts. Eur J Immunol 20:2439-2443
34. Walther Z, May LT, Sehgal PB (1988) Transcriptional regulation of the interferon-β2/B cell differentiation factor BSF-2/hepatocyte-stimulating factor gene in human fibroblasts by other cytokines. J Immunol 140:974-977
35. Weissler JC, Lipscomb MF, Lem VM, Toews GB (1986) Tumor killing by human alveolar macrophages and blod monocytes: Decreased cytotoxicity of human alveolar macrophages. Am Rev Respir Dis 134:532-537
36. Zhang Y, Lin JX, Vilcek J (1988) Synthesis of interleukin-6 (interferon β2/B cell stimulatory factor 2) in human fibroblast is triggered by an increase in intracellular cyclic AMP. J Biol Chem 263:6177-6182